4.2 Article

The genetic basis of phage susceptibility, cross- resistance and host-range in Salmonella

Journal

MICROBIOLOGY-SGM
Volume 167, Issue 12, Pages -

Publisher

MICROBIOLOGY SOC
DOI: 10.1099/mic.0.001126

Keywords

phage; salmonella; resistance; host; range; genome; wide; sigma factor; virulence; genetic screen

Categories

Funding

  1. Microbiology Program of the Innovative Genomics Institute, Berkeley
  2. NIH [S10RR029668, S10RR027303, OD018174]
  3. ENIGMA-Ecosystems and Networks Integrated with Genes and Molecular Assemblies
  4. U.S. Department of Energy, Office of Science, Office of Biological & Environmental Research [DE-AC02-05CH11231]

Ask authors/readers for more resources

The study identified 301 diverse host factors essential in phage infection in Salmonella enterica serovar Typhimurium, many of which are shared between multiple phages. Additionally, the research revealed the intricate interplay between RpoS and RpoN in phage cross-resistance.
Though bacteriophages (phages) are known to play a crucial role in bacterial fitness and virulence, our knowledge about the genetic basis of their interaction, cross-resistance and host -range is sparse. Here, we employed genome- wide screens in Salmonella enterica serovar Typhimurium to discover host determinants involved in resistance to eleven diverse lytic phages including four new phages isolated from a therapeutic phage cocktail. We uncovered 301 diverse host factors essential in phage infection, many of which are shared between multiple phages demonstrating potential cross-resistance mechanisms. We validate many of these novel findings and uncover the intricate interplay between RpoS, the virulence-associated general stress response sigma factor and RpoN, the nitrogen starvation sigma factor in phage cross-resistance. Finally, the infectivity pattern of eleven phages across a panel of 23 genome sequenced Salmonella strains indicates that additional constraints and interactions beyond the host factors uncovered here define the phage host range.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Dual-barcoded shotgun expression library sequencing for high-throughput characterization of functional traits in bacteria

Vivek K. Mutalik, Pavel S. Novichkov, Morgan N. Price, Trenton K. Owens, Mark Callaghan, Sean Carim, Adam M. Deutschbauer, Adam P. Arkin

NATURE COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

A versatile platform strain for high-fidelity multiplex genome editing

Robert G. Egbert, Harneet S. Rishi, Benjamin A. Adler, Dylan M. McCormick, Esteban Toro, Ryan T. Gill, Adam P. Arkin

NUCLEIC ACIDS RESEARCH (2019)

Article Biology

Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a

Gavin J. Knott, Brady F. Cress, Jun-Jie Liu, Brittney W. Thornton, Rachel J. Lew, Basem Al-Shayeb, Daniel J. Rosenberg, Michel Hammel, Benjamin A. Adler, Marco J. Lobba, Michael Xu, Adam P. Arkin, Christof Fellmann, Jennifer A. Doudna

ELIFE (2019)

Article Biochemistry & Molecular Biology

High-throughput mapping of the phage resistance landscape in E. coli

Vivek K. Mutalik, Benjamin A. Adler, Harneet S. Rishi, Denish Piya, Crystal Zhong, Britt Koskella, Elizabeth M. Kutter, Richard Calendar, Pavel S. Novichkov, Morgan N. Price, Adam M. Deutschbauer, Adam P. Arkin

PLOS BIOLOGY (2020)

Article Ecology

Systematic discovery of pseudomonad genetic factors involved in sensitivity to tailocins

Sean Carim, Ashley L. Azadeh, Alexey E. Kazakov, Morgan N. Price, Peter J. Walian, Lauren M. Lui, Torben N. Nielsen, Romy Chakraborty, Adam M. Deutschbauer, Vivek K. Mutalik, Adam P. Arkin

Summary: Tailocins are bactericidal protein complexes produced by various bacteria with high specificity, making them potential precision antibacterial agents. Research indicates that O-antigen composition and display are crucial factors defining sensitivity to Tailocins, while LPS thinning can increase sensitivity of resistant strains to Tailocins.

ISME JOURNAL (2021)

Article Multidisciplinary Sciences

A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens

Vivek K. Mutalik, Adam P. Arkin

Summary: At the current rate, the rise of antimicrobial-resistant infections is expected to have severe consequences. With limited new antibiotics in development, alternative solutions are needed. Bacteriophages offer a powerful alternative approach to combat bacterial infections. However, further development and systematic implementation of phage therapies are required. The proposed Phage Foundry framework aims to address knowledge and technological gaps in phage therapeutics and promote rational exploitation of phages for treatment.

ISCIENCE (2022)

Article Microbiology

Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing

Benjamin A. Adler, Tomas Hessler, Brady F. Cress, Arushi Lahiri, Vivek K. Mutalik, Rodolphe Barrangou, Jillian Banfield, Jennifer A. Doudna

Summary: In this study, the defensive capabilities of LbuCas13a protein were analyzed, and it was found to have robust antiviral activity against a wide range of phages. By leveraging LbuCas13a targeting, successful genome editing of multiple phages was achieved, demonstrating the versatility and potency of Cas13a as a generalizable tool for editing diverse biological entities.

NATURE MICROBIOLOGY (2022)

Review Biochemistry & Molecular Biology

Phage therapy: From biological mechanisms to future directions

Steffanie A. Strathdee, Graham F. Hatfull, Vivek K. Mutalik, Robert T. Schooley

Summary: Increasing antimicrobial resistance rates have prompted a resurgence in bacteriophage research as an alternative therapy. The ideal therapeutic phage should possess lytic properties, efficiently kill the bacterial host, and be well-characterized to ensure safety. This article reviews the current state of phage therapy, including biological mechanisms, clinical applications, challenges, and future directions involving naturally occurring and genetically modified or synthetic phages.
Article Biochemistry & Molecular Biology

Improved genome editing by an engineered CRISPR-Cas12a

Enbo Ma, Kai Chen, Honglue Shi, Elizabeth C. Stahl, Ben Adler, Marena Trinidad, Junjie Liu, Kaihong Zhou, Jinjuan Ye, Jennifer A. Doudna

Summary: In this study, CRISPR-Cas12a was engineered and evolved to improve its genome editing efficiency and ability to induce homology-directed repair (HDR) editing. This strategy can be applied to other CRISPR-Cas enzymes to enhance the efficacy of genome editing proteins.

NUCLEIC ACIDS RESEARCH (2022)

Article Biochemistry & Molecular Biology

Multicopy suppressor screens reveal convergent evolution of single-gene lysis proteins

Benjamin A. Adler, Karthik Chamakura, Heloise Carion, Jonathan Krog, Adam M. Deutschbauer, Ry Young, Vivek K. Mutalik, Adam P. Arkin

Summary: This study used a high-throughput genetic screen to identify genome-wide host suppressors of diverse single-gene lysis factors (Sgls). In addition to validating known mechanisms, the researchers discovered that the Sgl of PP7, a Pseudomonas aeruginosa ssRNA phage, targets MurJ, the flippase responsible for lipid II export, which was previously shown to be the target of the Sgl of coliphage M. These unrelated Sgls, which are predicted to have opposite membrane topology, represent a case of convergent evolution. Furthermore, the genetic screens revealed a common set of multicopy suppressors for uncharacterized Sgls, suggesting a shared or similar mechanism of action.

NATURE CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

CasPEDIA Database: a functional classification system for class 2 CRISPR-Cas enzymes

Benjamin A. Adler, Marena Trinidad, Daniel Bellieny-Rabelo, Elaine Zhang, Hannah M. Karp, Petr Skopintsev, Brittney W. Thornton, Rachel F. Weissman, Peter H. Yoon, Linxing Chen, Tomas Hessler, Amy R. Eggers, David Colognori, Ron Boger, Erin E. Doherty, Connor A. Tsuchida, Ryan Tran, Laura Hofman, Honglue Shi, Kevin M. Wasko, Zehan Zhou, Chenglong Xia, Muntathar J. Al-Shimary, Jaymin R. Patel, Vienna C. J. X. Thomas, Rithu Pattali, Matthew J. Kan, Anna Vardapetyan, Alana Yang, Arushi Lahiri, Michaela F. Maxwell, Andrew G. Murdock, Glenn C. Ramit, Hope R. Henderson, Roland W. Calvert, Rebecca S. Bamert, Gavin J. Knott, Audrone Lapinaite, Patrick Pausch, Joshua C. Cofsky, Erik J. Sontheimer, Blake Wiedenheft, Peter C. Fineran, Stan J. J. Brouns, Dipali G. Sashital, Brian C. Thomas, Christopher T. Brown, Daniela S. A. Goltsman, Rodolphe Barrangou, Virginius Siksnys, Jillian F. Banfield, David F. Savage, Jennifer A. Doudna

Summary: CRISPR-Cas enzymes play a crucial role in bacterial immunity and genome editing. CasPEDIA is a comprehensive database that summarizes the enzymatic properties of Cas enzymes, providing valuable resources for researchers.

NUCLEIC ACIDS RESEARCH (2023)

No Data Available